STOCK TITAN

BlueRiver Acquisition Stock Price, News & Analysis

BLUA NYSE

Company Description

BlueRiver Acquisition Corp. (BLUA) is a special purpose acquisition company (SPAC) domiciled in the Cayman Islands. According to company disclosures, it was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Its securities have traded under the ticker symbol BLUA.

BlueRiver Acquisition Corp. has focused on identifying a suitable business combination target rather than operating an ongoing commercial business of its own. As described in its public communications, the company’s structure allows it to pursue a merger or similar transaction, after which the combined entity may operate under a different name and business profile. Until such a transaction is completed, BlueRiver’s activities are largely limited to evaluating potential targets and managing the capital raised in its initial public offering.

Corporate structure and jurisdiction

The company is organized as a Cayman Islands exempted company. In its SEC filings, BlueRiver Acquisition Corp. refers to itself as a special purpose acquisition company, with ordinary shares that were initially sold to public investors in an initial public offering. The company’s governing documents, including its amended and restated memorandum and articles of association, set out deadlines by which it must complete a business combination or move toward winding up and redeeming public shares.

Listing history and trading venues

BlueRiver’s securities have been listed on multiple U.S. trading venues. The company has disclosed that its units, Class A ordinary shares and redeemable warrants were initially listed on the New York Stock Exchange and later transferred to NYSE American LLC. In one Business Wire announcement, BlueRiver stated that it intended to transfer its listing from the New York Stock Exchange to NYSE American and that it received written confirmation that it had been cleared to file an initial listing application with NYSE American. A subsequent release noted that BlueRiver received final approval for listing from NYSE American.

NYSE American later announced that its regulatory staff determined to commence proceedings to delist BlueRiver’s securities because the company did not consummate a business combination within the time period specified in its initial public offering registration statement. Following an appeal and the company’s later withdrawal of that appeal, NYSE American stated that it would suspend trading in BlueRiver’s Class A ordinary shares and units and apply to the Securities and Exchange Commission to delist the securities. An SEC Form 8-K filing identifies the Class A ordinary shares, units and redeemable warrants as trading on the OTC Expert Market, with BLUA, BLUA.U and BLUA.WS as the respective symbols.

Business combination efforts

BlueRiver Acquisition Corp. has described its purpose as effecting a business combination with one or more businesses. In a Business Wire communication, the company reported entering into an Agreement and Plan of Merger with Spinal Stabilization Technologies, LLC (SST) and a merger subsidiary. That communication explains that SST is a medical device company and that, upon closing of the proposed transaction, the combined company would operate as Spinal Stabilization Technologies and be listed on an approved stock exchange. BlueRiver also disclosed that it filed a registration statement with the SEC that includes a proxy statement related to the proposed transaction, and that additional documents related to the merger agreement would be filed with the SEC.

In a later press release, BlueRiver stated that it received a notice from NYSE American regarding the commencement of delisting proceedings because it had not completed a business combination within the required timeframe. In the same communication, the company noted that it agreed with SST to extend the date on which the merger agreement could be terminated if the closing had not occurred, moving the outside date from early February to the end of March of that year. These disclosures indicate that BlueRiver has pursued, but not yet completed, a business combination within the original timeframe set out in its charter and listing rules.

Charter provisions and extension votes

BlueRiver’s SEC filings describe how its charter governs the timeline for completing a business combination. A definitive proxy statement explains that the company’s existing charter provided a deadline by which it must complete an initial business combination, after which it would be required to cease operations except for winding up, redeem the public shares and, subject to applicable law, liquidate and dissolve. The same proxy statement presents an extension proposal to amend the charter so that the board of directors could, without another shareholder vote, extend the deadline by several three-month periods, up to a total of 66 months from the closing of the initial public offering.

An 8-K filing reports on an extraordinary general meeting at which shareholders voted on the extension proposal and an adjournment proposal. According to that filing, shareholders approved the extension proposal, allowing the board to elect to extend the date by which the company must complete a business combination, subject to the conditions described in the amended charter. The filing also notes that the adjournment proposal was not presented because there were sufficient votes to approve the extension proposal.

Capital held in trust

The proxy materials describe how proceeds from BlueRiver’s initial public offering were placed in a trust account. The company states that, upon closing of the offering, a specified amount was deposited in a U.S. trust account with a trustee and initially invested in U.S. government securities. The proxy statement discusses regulatory considerations under the Investment Company Act of 1940 for SPACs that hold trust assets in securities beyond a certain period. It further explains that BlueRiver converted the trust assets into cash in a non-interest bearing account and later deposited them in an interest-bearing demand deposit account at a bank, with interest accruing at a variable rate. These details illustrate how the company has managed its trust account while working toward a potential business combination.

Status as a SPAC and investor considerations

As a SPAC, BlueRiver Acquisition Corp. does not describe any operating business of its own in the provided materials. Instead, its disclosures focus on its structure, trust account, deadlines for completing a business combination and the regulatory framework under which it operates. Investors considering BLUA historically would have evaluated the company’s ability to identify and complete a suitable business combination within the time allowed by its charter and exchange rules, as well as the terms of any proposed transaction disclosed in SEC filings and proxy statements.

Because NYSE American has initiated delisting proceedings and suspended trading in BlueRiver’s securities, and because the company has sought extensions to its business combination deadline, the trading status and future of BLUA depend on regulatory actions, shareholder approvals and the outcome of any proposed business combination. The SEC filings and proxy materials provide detailed information on these processes, including shareholder voting results, charter amendments and the handling of public share redemptions in the event of a winding up.

Stock Performance

$—
0.00%
0.00
Last updated:
+0.57%
Performance 1 year
$106.1M

Financial Highlights

-$2,537,517
Net Income (TTM)
-$292,465
Operating Cash Flow
-$2,455,790
Revenue (TTM)

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of BlueRiver Acquisition (BLUA)?

The current stock price of BlueRiver Acquisition (BLUA) is $11.1 as of February 7, 2025.

What is the market cap of BlueRiver Acquisition (BLUA)?

The market cap of BlueRiver Acquisition (BLUA) is approximately 106.1M. Learn more about what market capitalization means .

What is the net income of BlueRiver Acquisition (BLUA)?

The trailing twelve months (TTM) net income of BlueRiver Acquisition (BLUA) is -$2,537,517.

What is the operating cash flow of BlueRiver Acquisition (BLUA)?

The operating cash flow of BlueRiver Acquisition (BLUA) is -$292,465. Learn about cash flow.

What is the current ratio of BlueRiver Acquisition (BLUA)?

The current ratio of BlueRiver Acquisition (BLUA) is 0.01, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of BlueRiver Acquisition (BLUA)?

The operating income of BlueRiver Acquisition (BLUA) is -$2,455,790. Learn about operating income.

What is BlueRiver Acquisition Corp. (BLUA)?

BlueRiver Acquisition Corp. is a special purpose acquisition company domiciled in the Cayman Islands. It was formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, rather than to operate an independent commercial business.

How does BlueRiver Acquisition Corp. structure its business as a SPAC?

BlueRiver raised capital through an initial public offering of units consisting of Class A ordinary shares and redeemable warrants. The proceeds were placed in a trust account, and the company’s charter sets deadlines by which it must complete a business combination or move toward redeeming public shares and winding up, subject to shareholder approval and applicable law.

Where have BLUA securities been listed and traded?

BlueRiver’s securities were initially listed on the New York Stock Exchange and later transferred to NYSE American LLC. NYSE American subsequently determined to commence delisting proceedings and suspend trading in the company’s securities. An SEC Form 8-K identifies the Class A ordinary shares, units and redeemable warrants as quoted on the OTC Expert Market under the symbols BLUA, BLUA.U and BLUA.WS.

Why did NYSE American move to delist BlueRiver Acquisition Corp.?

According to an NYSE American announcement, the exchange’s regulatory staff determined to commence delisting proceedings for BlueRiver’s securities because the company failed to consummate a business combination within 36 months of the effectiveness of its initial public offering registration statement, or within the shorter period specified in that registration statement.

Has BlueRiver Acquisition Corp. pursued a business combination?

Yes. BlueRiver disclosed that it entered into an Agreement and Plan of Merger with Spinal Stabilization Technologies, LLC and a merger subsidiary. The parties announced that, upon closing of the proposed transaction, the combined company would operate as Spinal Stabilization Technologies and be listed on an approved stock exchange. BlueRiver also filed a registration statement with the SEC that includes a proxy statement related to the proposed transaction.

What extensions to its business combination deadline has BlueRiver sought?

A definitive proxy statement describes an extension proposal to amend BlueRiver’s charter so that its board could extend the deadline to complete a business combination by several three-month periods, up to a total of 66 months from the closing of the initial public offering. An 8-K filing reports that shareholders approved this extension proposal at an extraordinary general meeting.

How does BlueRiver manage the funds raised in its IPO?

BlueRiver states that, upon closing its initial public offering, a specified amount of proceeds was placed in a U.S. trust account with a trustee and initially invested in U.S. government securities. The company later converted those assets into cash in a non-interest bearing account and then deposited them in an interest-bearing demand deposit account at a bank, while it worked toward completing an initial business combination.

What happens to BlueRiver’s public shares if no business combination is completed?

Under the charter provisions described in the proxy materials, if BlueRiver does not consummate a business combination within the specified period, it must cease operations except for winding up, redeem the public Class A ordinary shares for cash from the trust account and, subject to shareholder and director approval and Cayman Islands law, liquidate and dissolve. The extension amendments adjust the timeline but retain this general framework.

What role do shareholder votes play in BlueRiver’s timeline?

Shareholders vote on key matters such as amendments to the charter that extend the deadline for completing a business combination. An 8-K filing notes that an extraordinary general meeting was held to consider an extension proposal and an adjournment proposal, and that shareholders approved the extension proposal, allowing the board to elect to extend the deadline within the limits set out in the amended charter.

Is BlueRiver Acquisition Corp. an operating medical device company?

No. BlueRiver describes itself as a special purpose acquisition company formed to pursue a business combination. While it has entered into a proposed business combination with Spinal Stabilization Technologies, LLC, a medical device company, BlueRiver’s own disclosures characterize it as a SPAC rather than an operating medical device business.